Latest Revenue Growth News

NZME Limited has upgraded its FY25 Operating EBITDA guidance, signaling stronger-than-expected financial performance despite economic headwinds. The company now expects earnings between $59 million and $62 million, up from its earlier forecast.

Hydrix Limited reports a robust quarter with $3.35 million in sales, a 7% revenue increase, and a strong international client base, while advancing US market ventures.

Assetora Limited has reopened its flagship fund under a new name, secured a $3 million strategic investment, and reported its first positive operating cashflow since adopting its fund-management model.

Carbonxt Group Limited has advanced its Kentucky activated carbon facility ownership to 45.9%, with kiln commissioning underway and a projected 200% sales increase. The company also raised $1.3 million to support growth amid strong regulatory demand for PFAS filtration products.

SOCO Corporation has returned to profitability in FY25, driven by strategic contract wins and client diversification. The company is now focusing on expanding recurring revenues and leveraging AI and cybersecurity capabilities for future growth.

SOCO Corporation Ltd has reported a return to profitability in FY25, driven by revenue growth and strategic investments. The company is now focused on disciplined execution and client diversification to sustain momentum into FY26.

Ashley Services reported a challenging FY25 with a 7.3% revenue decline but kicked off FY26 with record quarterly revenues and improved profitability, signaling a strategic turnaround.

Motio Limited has raised $1.73 million through a placement to accelerate its digital display network expansion and repay debt early, aiming to reach profitability sooner.

dorsaVi reports breakthrough RRAM sensor performance and secures a major US physical therapy deal, backed by a $5 million capital raise and new leadership appointments.

The Calmer Co. International Limited has delivered its strongest quarter yet, with revenue surging 26% to $2.4 million and operating cash outflows dropping to a historic low. Strategic growth across retail, e-commerce, and B2B channels underpins its confident path to breakeven.

Microba Life Sciences reports robust Q1 FY26 growth in microbiome diagnostics, introduces workflow-enhancing features, and prepares for key therapeutic deal catalysts by year-end.

IODM Limited has reported a record-breaking first quarter for FY26, with cash receipts soaring 76% year-on-year, driven predominantly by explosive growth in its UK Education segment. The company also made strategic advances in North America and Japan, setting the stage for broader global expansion.